文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

探讨循环 miRNA 特征在骨肉瘤检测中的应用:基于生物信息学的分析和验证。

Exploring circulating MiRNA signature for osteosarcoma detection: Bioinformatics-based analyzing and validation.

机构信息

Department of Cellular and Molecular Biology, Faculty of Sciences and Advanced Technology in Biology, University of Science and Culture, Tehran, Iran.

Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran; Experimental Cancer Medicine, Institution for Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.

出版信息

Pathol Res Pract. 2024 Nov;263:155615. doi: 10.1016/j.prp.2024.155615. Epub 2024 Oct 1.


DOI:10.1016/j.prp.2024.155615
PMID:39378797
Abstract

Early detection followed by efficient treatment still remain a considerable challenge for osteosarcoma (OS), indicating the importance of emerging innovative diagnostic methods. Circulating miRNAs offer a promising and non-invasive approach to assess the OS molecular landscapes. This study utilized RNAseq data from OS plasma miRNA expression profiles (PRJEB30542) and PCR Array data (GSE65071) from GEO and ENA databases. In total, 43 miRNAs demonstrated significant differential expression in OS samples of training dataset. A diagnostic model, including hsa-miR-30a-5p, hsa-miR-556-3p, hsa-miR-200a-3p, and hsa-miR-582-5p was identified through multivariate logistic regression analysis and demonstrated significant efficacy in differentiating OS patients from healthy controls in the validation group (AUC: 0.917, sensitivity: 1, specificity: 0.85). The result of target gene prediction and functional enrichment analyses revealed significant associations with terms such as epithelial morphogenesis, P53 and Wnt signaling pathways, and neoplasm metastasis. Further bioinformatics-based evaluations showed that the down-regulation of these miRNAs significantly correlates with poor prognosis and lower survival rate in OS patients and propose their tumor suppressor function in pathogenesis of OS. Furthermore, the study developed a miRNA-mRNA subnetwork that connects these miRNAs to the P53 and Wnt signaling pathways, which are critical pathways with oncogenic effects on OS progression. This comprehensive approach not only presents a promising diagnostic model but also proposes potential molecular markers for OS early diagnosis, making prognosis, and targeted therapy. The identified miRNA-mRNA functional axis holds promise as a valuable resource for further research in understanding OS pathogenesis and establishing therapeutic modalities.

摘要

早期检测和有效治疗仍然是骨肉瘤(OS)的一个重大挑战,这表明新兴创新诊断方法的重要性。循环 miRNA 提供了一种有前途的非侵入性方法来评估 OS 的分子图谱。本研究利用了 OS 血浆 miRNA 表达谱的 RNAseq 数据(PRJEB30542)和 GEO 和 ENA 数据库中的 PCR 阵列数据(GSE65071)。在训练数据集的 OS 样本中,共有 43 个 miRNA 表现出显著的差异表达。通过多元逻辑回归分析确定了一个包括 hsa-miR-30a-5p、hsa-miR-556-3p、hsa-miR-200a-3p 和 hsa-miR-582-5p 的诊断模型,该模型在验证组中显示出区分 OS 患者和健康对照的显著疗效(AUC:0.917,灵敏度:1,特异性:0.85)。靶基因预测和功能富集分析的结果显示与上皮形态发生、P53 和 Wnt 信号通路以及肿瘤转移等术语存在显著关联。进一步基于生物信息学的评估表明,这些 miRNA 的下调与 OS 患者的预后不良和生存率降低显著相关,并提出了它们在 OS 发病机制中的肿瘤抑制功能。此外,该研究还开发了一个 miRNA-mRNA 子网,将这些 miRNA 与 P53 和 Wnt 信号通路连接起来,这些信号通路对 OS 进展具有致癌作用。这种综合方法不仅提出了一种有前途的诊断模型,还提出了用于 OS 早期诊断、预后和靶向治疗的潜在分子标志物。所鉴定的 miRNA-mRNA 功能轴有望成为进一步研究 OS 发病机制和建立治疗方式的有价值资源。

相似文献

[1]
Exploring circulating MiRNA signature for osteosarcoma detection: Bioinformatics-based analyzing and validation.

Pathol Res Pract. 2024-11

[2]
A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.

Int J Clin Oncol. 2019-5-20

[3]
Identification of plasma miR-4505, miR-4743-5p and miR-4750-3p as novel diagnostic biomarkers for coronary artery disease in patients with type 2 diabetes mellitus: a case-control study.

Cardiovasc Diabetol. 2024-7-29

[4]
Integrated Analysis of Competing Endogenous RNAs Network Reveals Potential Signatures in Osteosarcoma Development.

Technol Cancer Res Treat. 2020

[5]
Machine learning and experimental analyses identified miRNA expression models associated with metastatic osteosarcoma.

Biochim Biophys Acta Mol Basis Dis. 2024-10

[6]
Identification of potential micro-messenger RNAs (miRNA-mRNA) interaction network of osteosarcoma.

Bioengineered. 2021-12

[7]
Role of miRNA-542-5p in the tumorigenesis of osteosarcoma.

FEBS Open Bio. 2020-4

[8]
Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.

Oncol Rep. 2017-6

[9]
Identification of circulating miR-663a as a potential biomarker for diagnosing osteosarcoma.

Pathol Res Pract. 2019-4-6

[10]
Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.

Oncotarget. 2017-5-16

引用本文的文献

[1]
LncSNHGs: new targets in osteosarcoma.

Cancer Gene Ther. 2025-8-16

[2]
Comparison of Differentially Expressed Genes in Human and Canine Osteosarcoma.

Life (Basel). 2025-6-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索